Changes in choriocapillaris fenestration of rat eyes after intravitreal bevacizumab injection

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 8, 2009, Pages 1089-1094

  Shimomura, Yukiko ^a   Hirata, Akira ^a   Ishikawa, Shinichiro ^a   Okinami, Satoshi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Bevacizumab; Choriocapillaris; Fenestration; Scanning electron microscopy

Indexed keywords

BEVACIZUMAB; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; DRUG SAFETY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SCANNING ELECTRON MICROSCOPY; TISSUE PERFUSION; TISSUE STRUCTURE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; CHOROID; ENDOTHELIUM, VASCULAR; INJECTIONS; MALE; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, WISTAR; RETINAL PIGMENT EPITHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 67651085069     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1054-1     Document Type: Article

References (29)

1. Kvanta A, Algvere PV, Berglin L, Seregard S (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37:1929-1934
2. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487. doi: 10.1056/ NEJM199412013312203
3. Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108(Pt 6):2369-2379
4. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 155:421-428
5. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342. doi: 10.1056/NEJMoa032691
6. Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U (2007) Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48:2814-2823. doi: 10.1167/iovs.06-1171
7. Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336-339
8. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363-372. doi: 10.1016/ j.ophtha.2005.11.019
9. Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331-335
10. Avery RL (2006) Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 26:352-354. doi: 10.1097/00006982-200603000-00016
11. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A (2006) Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113:1695-1705. doi: 10.1016/j.ophtha.2006.05.064
12. Jonas JB, Harder B, Spandau UH, Kamppeter BA, Libondi T, Sauder G (2006) Bevacizumab for occult subfoveal neovascularization in age-related macular degeneration. Eur J Ophthalmol 16:774-775
13. Shah MA, Ilson D, Kelsen DP (2005) Thromboembolic events in gastric cancer: High incidence in patients receiving irinotecan- and bevacizumab-based therapy. J Clin Oncol 23:2574-2576. doi: 10.1200/ JCO.2005.81.908
14. Korte GE, Reppucci V, Henkind P (1984) RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci 25:1135-1145
15. Burns MS, Hartz MJ (1992) The retinal pigment epithelium induces fenestration of endothelial cells in vivo. Curr Eye Res 11:863-873. doi: 10.3109/02713689209033484
16. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK, Olsen BR (2005) Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 167:1451-1459
17. Krstić RV (1994) Human Microscopic Anatomy: An Atlas for Students of Medicine and Biology. Springer, New York
18. Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU, Schraermeyer U (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995-1002. doi: 10.1016/j.ajo.2007.03.007
19. Baluk P, Hirata A, Thurston G, Fujiwara T, Neal CR, Michel CC, McDonald DM (1997) Endothelial gaps: Time course of formation and closure in inflamed venules of rats. Am J Physiol 272:L155-L170
20. Hirata A, Baluk P, Fujiwara T, McDonald DM (1995) Location of focal silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy. Am J Physiol 269:L403-L418
21. Korte GE, Gerszberg T, Pua F, Henkind P (1986) Choriocapillaris atrophy after experimental destruction of the retinal pigment epithelium in the rat. A study in thin sections and vascular casts. Acta Anat (Basel) 127:171-175. doi: 10.1159/000146277
22. Leonard DS, Zhang XG, Panozzo G, Sugino IK, Zarbin MA (1997) Clinicopathologic correlation of localized retinal pigment epithelium debridement. Invest Ophthalmol Vis Sci 38:1094-1109
23. Ioannidou S, Deinhardt K, Miotla J, Bradley J, Cheung E, Samuelsson S, Ng Y, Shima DT (2006) An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis. Proc Natl Acad Sci USA 103:16770-16775. doi: 10.1073/pnas.0603501103
24. Bock F, Onderka J, Dietrich T, Bachmann B, Kruse FE, Paschke M, Zahn G, Cursiefen C (2007) Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci 48:2545-2552. doi: 10.1167/iovs.06-0570
25. Barros LF, Belfort R Jr (2007) The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea. An Acad Bras Cienc 79:389-394. doi: 10.1590/S0001-37652007000300004
26. Manzano RP, Peyman GA, Khan P, Carvounis PE, Kivilcim M, Ren M, Lake JC, Chevez-Barrios P (2007) Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin). Br J Ophthalmol 91:804-807. doi: 10.1136/bjo.2006.107912
27. Yu L, Wu X, Cheng Z, Lee CV, LeCouter J, Campa C, Fuh G, Lowman H, Ferrara N (2008) Interaction between bevacizumab and murine VEGF-A: A reassessment. Invest Ophthalmol Vis Sci 49:522-527. doi: 10.1167/ iovs.07-1175
28. Lu F, Adelman RA (2009) Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization? Graefes Arch Clin Exp Ophthalmol 247(2):171-177
29. Klettner A, Roider J (2008) Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: Efficacy and possible additional pathways. Invest Ophthalmol Vis Sci 49:4523-4527. doi: 10.1167/iovs.08-2055